Zagazig University Digital Repository
Home
Thesis & Publications
All Contents
Publications
Thesis
Graduation Projects
Research Area
Research Area Reports
Search by Research Area
Universities Thesis
ACADEMIC Links
ACADEMIC RESEARCH
Zagazig University Authors
Africa Research Statistics
Google Scholar
Research Gate
Researcher ID
CrossRef
The outcome of combined treatment with ombitasvir-paritaprevirritonavir, sofosbuvir with or without ribavirin as salvage therapy for Egyptian HCV experienced patients: A single center study
Faculty
Medicine
Year:
2018
Type of Publication:
ZU Hosted
Pages:
Authors:
Walid Abdel-Fattah Mohamed Ismail
Staff Zu Site
Abstract In Staff Site
Journal:
Comparative Immunology, Microbiology and Infectious Diseases www.ddtjournal.com
Volume:
Keywords :
, outcome , combined treatment with ombitasvir-paritaprevirritonavir, sofosbuvir
Abstract:
We aimed to investigate the efficacy and safety of combination of sofosbuvir with ombitasvir, paritaprevir, and ritonavir ± ribavirin as a retreatment option for experienced Egyptian patients who failed previous sofosbuvir, daclatasvir ± ribavirin therapy. A total of 75 treatment-experienced patients were allocated for the completion of their treatment period according to criteria formed by the national committee for control of viral hepatitis. The enrolled patients were followed up throughout treatment, at the end of treatment and 3 months after the end of the treatment by clinical evaluation and laboratory investigations. 27 patients were treated with sofosbuvir with ombitasvir, paritaprevir, and ritonavir plus ribavirin for 12 weeks while 48 patients were treated with sofosbuvir with ombitasvir, paritaprevir, and ritonavir without ribavirin for 24 weeks. The per-protocol sustained virological response at week 12 (SVR12) rate was 100% in both groups while the intentionto-treat SVR12 was 93.4% in all patients, 97.9% in the 24 weeks group and 85.2% in the 12 weeks group. The regimen was well tolerated and the most common adverse effects observed across treatment and during follow-up period included fatigue (38.6%) and headache (29.3%), withdrawal due to adverse effects occurred in 6.6%. We can conclude that retreatment with sofosbuvir with ombitasvir, paritaprevir, and ritonavir ± ribavirin is well tolerated and achieved high SVR12 rates in chronic HCV Egyptian patients with previous sofosbuvir plus daclatasvir treatment failure. Ribavirin free regimen for 24 weeks exerted significant lesser adverse effects.
Author Related Publications
Walid Abdel-Fattah Mohamed Ismail, "Evaluation of liver fat content with magnetic resonance spectroscopy in overweight subjects as an early detector o fatty liver disease and correlation with liver biopsy", JHGR, 2014
More
Walid Abdel-Fattah Mohamed Ismail, "THE YEILD OF MAPPING BIOPSY IN ENDOSCOPICALLY NORMALOLON AND ITSCORRELATION WITH BIOPSY", JHGR, 2014
More
Walid Abdel-Fattah Mohamed Ismail, "DOES VISCERAL ADIPOSITY INFLUENCE THE STANDARD OF CARE FOR HEPATITIS C PATIENTS", JASR, 2014
More
Walid Abdel-Fattah Mohamed Ismail, "Prevalence of occult hepatitis C virus infection in patients who achieved sustained virologic response to direct-acting antiviral agents", Le Infezioni in Medicina, 2018
More
Walid Abdel-Fattah Mohamed Ismail, "Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection", WHO Fact sheet No. 164, June 2011, 2011
More
Department Related Publications
Ehab Mohamed Ahmed Salm, "دور الانترولوكين 1 بيتا في امراض المعدة والاثني عشر المصاحبة للبكتريا الحلزونية البوابية", لايوجد, 1900
More
Hamed Abdelaziz Deraz, "مدى انتشار الالتهاب الكبدى الفيروس ب ، س فى الشرقية ", لايوجد, 1900
More
Helmy Mohamed Youssef Elgendy, "تقييم طريقة الباكتك 960: ذو النظام الى مقارنة مع الطريقة التكبير " المبزالجينى والوسط الصلب لنمو وتحديد بكتريا الدرن من العينات الخاصة بمرض الدرن", لايوجد, 1900
More
Helmy Mohamed Youssef Elgendy, "مقارنة وسيلة استخدام العينات المأخوذة بالابر الرقيقة بواسطة الموجات الصوتية مع الوسائل للاخرى فى تشخيص اورام الكبد", لايوجد, 1900
More
Helmy Mohamed Youssef Elgendy, "تحديد الاصابة بميكروب الكامبيليوباكتر فى 200 مريضا مصابا بعسر الهضم بطريقة أخذ عينات من المعدة واختبارها بطريقة اليورياز", لايوجد, 1900
More
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
شراقوة
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف